Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Penile Neoplasms 1Oropharyngeal Neoplasms 1Head and Neck Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Anus Neoplasms 1

Interventions

Cisplatin 14Radiotherapy, Intensity-Modulated 12pembrolizumab 7Radiotherapy 7Magnetic Resonance Spectroscopy 7Specimen Handling 6Platinum 6Carboplatin 6Radiation 51,2-diaminocyclohexaneplatinum II citrate 5Taxes 3Surveys and Questionnaires 3Paclitaxel 3Nivolumab 3Fluorodeoxyglucose F18 3Biopsy 3durvalumab 2Drug Therapy 2prednylidene 1peposertib 1niraparib 1exifone 1entinostat 1dostarlimab 1deltacortene 1dehydroftorafur 1cemiplimab 1bintrafusp alfa protein, human 1atezolizumab 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Oropharyngeal Neoplasms × bintrafusp alfa protein, human × Clear all
NCT04708470 2026-04-06

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
55 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡